Status:
COMPLETED
Post-Market Clinical Study of the CardioFocus Endoscopic Ablation System - Adaptive Contact (CF-EAS-AC) for the Treatment of Symptomatic Atrial Fibrillation
Lead Sponsor:
CardioFocus
Conditions:
Atrial Fibrillation
Eligibility:
All Genders
18-70 years
Phase:
PHASE4
Brief Summary
The purpose of this study is to confirm the safety and effectiveness of the CardioFocus Endoscopic Ablation System with Adaptive Contact in the treatment of atrial fibrillation.
Eligibility Criteria
Inclusion
- Symptomatic, Paroxysmal Atrial Fibrillation (AF)
- 18 to 70 Years of age
- Others
Exclusion
- Generally good overall health as determined by multiple criteria
- Willing to participate in a study
- Others
Key Trial Info
Start Date :
September 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2012
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT01196923
Start Date
September 1 2010
End Date
June 1 2012
Last Update
July 27 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centro Cardiologico Monzino
Milan, Italy